SMAD7 and myeloid sarcoma: A new finding has uncovered the contribution of autoimmunity in an unconstrained mouse model of MS to the outflow of the changing development factor-beta (TGF-β) inhibitor, Smad7, in digestive CD4+ T cells [88].